Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Secondhand cannabis emissions/smoke exposure
Locations
1
United States
Zuckerberg San Francisco General Hospital
San Francisco, California, United States
Start Date
September 1, 2023
Primary Completion Date
June 30, 2025
Completion Date
June 30, 2026
Last Updated
September 11, 2023
NCT00090662
NCT06290258
NCT07310264
NCT06716502
NCT07483606
NCT06342713
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions